The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant loss of -35.64% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -19.60%. Over the past 30 days, the price of SGMO has leaped by -34.35%. And in the last five days, it has fallen by -19.94%.
Sangamo Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $3.18 on 11/08/24 and a low of $0.30 for the same time frame on 07/05/24.
52-week price history of SGMO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Sangamo Therapeutics Inc’s current trading price is -79.35% away from its 52-week high, while its distance from the 52-week low is 115.95%. The stock’s price range during this period has varied between$0.30 and $3.18. The Sangamo Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 56.7 million for the day, a figure considerably higher than their average daily volume of 5.43 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Sangamo Therapeutics Inc (SGMO) has experienced a quarterly decline of -41.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 147.52M and boasts a workforce of 183 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4554, with a change in price of -2.1535. Similarly, Sangamo Therapeutics Inc recorded 7,254,769 in trading volume during the last 100 days, posting a change of -76.64%.
SGMO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SGMO stands at 1.34. Similarly, the long-term debt-to-equity ratio is also 1.15.
SGMO Stock Stochastic Average
Sangamo Therapeutics Inc’s raw stochastic average for the past 50 days is presently 12.91%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 21.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.95% and 13.90%, respectively.
